$87.2 Million is the total value of PERKINS CAPITAL MANAGEMENT INC's 116 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RMTI | Buy | ROCKWELL MED INC | $3,623,000 | +0.8% | 478,650 | +0.0% | 4.15% | -7.7% |
| CSII | Buy | CARDIOVASCULAR SYS INC DEL | $2,051,000 | +108.9% | 111,600 | +17.8% | 2.35% | +91.3% |
| SNAK | Buy | INVENTURE FOODS INC | $1,560,000 | +321.6% | 199,750 | +205.0% | 1.79% | +286.2% |
| IZEA | Buy | IZEA INC | $1,494,000 | +46.2% | 196,035 | +36.9% | 1.71% | +33.9% |
| QUMU | Buy | QUMU CORP | $1,332,000 | +112.4% | 300,010 | +120.6% | 1.53% | +94.5% |
| ATRC | Buy | ATRICURE INC | $1,202,000 | -15.2% | 85,100 | +1.1% | 1.38% | -22.3% |
| IRIX | Buy | IRIDEX CORP | $1,195,000 | +95.6% | 80,800 | +35.1% | 1.37% | +79.1% |
| BSX | New | BOSTON SCIENTIFIC CORP | $1,184,000 | – | 50,650 | +100.0% | 1.36% | – |
| CGIX | Buy | CANCER GENETICS INC | $1,157,000 | +120.4% | 581,200 | +214.2% | 1.33% | +101.8% |
| TEAR | Buy | TEARLAB CORP | $1,123,000 | +40.2% | 1,755,242 | +38.0% | 1.29% | +28.3% |
| CAB | Buy | CABELAS INC | $1,076,000 | +11.9% | 21,500 | +8.9% | 1.23% | +2.4% |
| ABT | Buy | ABBOTT LABS | $1,025,000 | +1.4% | 26,075 | +7.9% | 1.18% | -7.1% |
| USAT | Buy | USA TECHNOLOGIES INC | $1,018,000 | +312.1% | 238,400 | +320.8% | 1.17% | +277.7% |
| JCI | Buy | JOHNSON CTLS INC | $873,000 | +16.6% | 19,725 | +2.6% | 1.00% | +6.7% |
| FUL | New | FULLER H B CO | $823,000 | – | 18,700 | +100.0% | 0.94% | – |
| CYTX | New | CYTORI THERAPEUTICS INC | $811,000 | – | 387,852 | +100.0% | 0.93% | – |
| ANGO | New | ANGIODYNAMICS INC | $644,000 | – | 44,850 | +100.0% | 0.74% | – |
| VZ | Buy | VERIZON COMMUNICATIONS INC | $605,000 | +152.1% | 10,830 | +144.5% | 0.69% | +131.3% |
| EGHT | New | 8X8 INC NEW | $552,000 | – | 37,800 | +100.0% | 0.63% | – |
| GEOS | Buy | GEOSPACE TECHNOLOGIES CORP | $494,000 | +47.5% | 30,150 | +11.0% | 0.57% | +35.1% |
| CR | New | CRANE CO | $465,000 | – | 8,200 | +100.0% | 0.53% | – |
| USPH | New | U S PHYSICAL THERAPY INC | $437,000 | – | 7,250 | +100.0% | 0.50% | – |
| BMY | New | BRISTOL MYERS SQUIBB CO | $414,000 | – | 5,625 | +100.0% | 0.48% | – |
| ENTL | New | ENTELLUS MED INC | $411,000 | – | 22,500 | +100.0% | 0.47% | – |
| EDAP | New | EDAP TMS S Asponsored adr | $391,000 | – | 118,000 | +100.0% | 0.45% | – |
| PFIE | New | PROFIRE ENERGY INC | $309,000 | – | 278,537 | +100.0% | 0.35% | – |
| CASC | New | CASCADIAN THERAPEUTICS INC | $290,000 | – | 307,400 | +100.0% | 0.33% | – |
| TAP | New | MOLSON COORS BREWING COcl b | $288,000 | – | 2,850 | +100.0% | 0.33% | – |
| ARCI | Buy | APPLIANCE RECYCLING CTRS AME | $209,000 | -1.4% | 180,254 | +0.1% | 0.24% | -9.4% |
| MMSI | New | MERIT MED SYS INC | $208,000 | – | 10,500 | +100.0% | 0.24% | – |
| MU | New | MICRON TECHNOLOGY INC | $203,000 | – | 14,750 | +100.0% | 0.23% | – |
| APPY | New | VENAXIS INC | $165,000 | – | 47,092 | +100.0% | 0.19% | – |
| GIG | New | GIGPEAK INC | $135,000 | – | 69,000 | +100.0% | 0.16% | – |
| SQNM | Buy | SEQUENOM INC | $123,000 | -28.9% | 134,150 | +9.2% | 0.14% | -35.0% |
| DAKPQ | Buy | DAKOTA PLAINS HLDGS INC | $108,000 | +151.2% | 977,500 | +104.7% | 0.12% | +129.6% |
| DXTRQ | New | DEXTERA SURGICAL INC | $93,000 | – | 51,403 | +100.0% | 0.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-07-20
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEOGENOMICS INC | 41 | Q3 2023 | 7.8% |
| LILY ELI & CO | 41 | Q3 2023 | 6.9% |
| PFIZER INC | 41 | Q3 2023 | 2.9% |
| ATTUNITY LTD | 41 | Q3 2023 | 3.6% |
| EXPEDITORS INTL WASH INC | 41 | Q3 2023 | 2.3% |
| CVS HEALTH CORP | 41 | Q3 2023 | 1.6% |
| DONALDSON INC | 41 | Q3 2023 | 1.3% |
| VERIZON COMMUNICATIONS INC | 41 | Q3 2023 | 1.0% |
| US BANCORP DEL | 41 | Q3 2023 | 0.8% |
| BAXTER INTL INC | 40 | Q3 2023 | 14.1% |
View PERKINS CAPITAL MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BIOLASE, INC | May 15, 2023 | 689,196 | 2.1% |
| FlexShopper, Inc. | February 09, 2023 | 1,281,460 | 5.9% |
| Avinger Inc | February 14, 2020 | 891,761 | 5.2% |
| Black Ridge Oil & Gas, Inc. | February 15, 2019 | 30,021,032 | 6.3% |
| CANCER GENETICS, INC | February 15, 2019 | 1,135,250 | 4.0% |
| TearLab Corp | February 15, 2019 | 1,666,294 | 13.1% |
| Xtant Medical Holdings, Inc. | February 15, 2019 | 684,408 | 3.6% |
| TearLab Corp | January 26, 2018 | 4,300,655 | 40.1% |
| BIO KEY INTERNATIONAL INC | February 09, 2017 | 274,900 | 4.4% |
| EnteroMedics Inc | February 09, 2017 | 1,455 | 0.0% |
View PERKINS CAPITAL MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-09 |
| 13F-HR | 2024-01-22 |
| 13F-HR | 2023-11-02 |
| 13F-HR | 2023-07-21 |
| SC 13G/A | 2023-05-15 |
| 13F-HR | 2023-05-09 |
| SC 13G/A | 2023-02-09 |
| SC 13G | 2023-02-09 |
| 13F-HR | 2023-01-26 |
| 13F-HR | 2022-10-24 |
View PERKINS CAPITAL MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.